Table 2.
Association of miR-21 expression level in glioma tissues with gender, age, Karnofsky performance score (KPS) and World Health Organization (WHO) grade
| Clinicopathological features | No. of cases |
miR-21 expression |
P
|
|
|---|---|---|---|---|
| Low (n, %) | High (n,%) | |||
|
WHO Grade |
|
|
|
<0.001 |
| I |
31 |
31 (100%) |
0 (0%) |
|
| II |
30 |
30 (100%) |
0 (0%) |
|
| III |
32 |
18 (56.3%) |
14 (43.7%) |
|
| IV |
59 |
3 (5%) |
56 (95%) |
|
|
Gender |
|
|
|
0.34 |
| Male |
78 |
45 (57.7%) |
33 (42.3%) |
|
| Female |
74 |
37 (50%) |
37 (50%) |
|
|
Age |
|
|
|
0.23 |
| <50 |
91 |
49 (53.8%) |
42 (46.2%) |
|
| ≥50 |
61 |
33 (54.1%) |
28 (45.9%) |
|
|
KPS |
|
|
|
<0.001 |
| ≥70 |
62 |
57 (91.9%) |
5 (8.1%) |
|
| <70 | 90 | 25 (27.8%) | 65 (72.2%) | |